ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near San Francisco, CA, USA:

Olaparib in Metastatic Breast Cancer

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

San Francisco, California, United States and 19 other locations

This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...

Enrolling
Breast Cancer
Drug: Talazoparib

Phase 2

Mass General Brigham
Mass General Brigham

San Francisco, California, United States and 6 other locations

This prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer...

Enrolling
Breast Cancer Female
Device: Breast Cancer Locator (BCL) guided partial mastectomy
Device: Wire Localized (WL) partial mastectomy
CairnSurgical

Walnut Creek, California, United States and 25 other locations

This purpose of this study is to test if talazoparib is safe and evaluate its response to advanced breast cancer associated with mu...

Enrolling
Breast Cancer
Advanced Breast Cancer
Drug: Talazoparib Tosylate

Phase 2

Stanford University
Stanford University

Stanford, California, United States

This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...

Active, not recruiting
Breast Cancer
Drug: Utomilumab
Drug: Vinorelbine

Phase 2

Adrienne G. Waks

San Francisco, California, United States and 16 other locations

This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...

Active, not recruiting
Metastatic Breast Cancer
FGFR 1 High Amplification
Drug: Futibatinib
Drug: Futibatinib plus Fulvestrant

Phase 2

Taiho Pharma
Taiho Pharma

San Francisco, California, United States and 36 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

San Francisco, California, United States and 62 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

San Francisco, California, United States and 117 other locations

together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: trastuzumab deruxtecan
Drug: tucatinib

Phase 2

Seagen
Seagen

San Francisco, California, United States and 32 other locations

Locations recently updated

with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...

Enrolling
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Drug: Alisertib
Drug: Endocrine therapy

Phase 2

Puma Biotechnology
Puma Biotechnology

San Francisco, California, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems